Kataoka et al., 2023
ViewPDF| Publication | Publication Date | Title |
|---|---|---|
| Naruse et al. | Systematic Treatment Approach to Ventricular Tachycardia in Cardiac Sarcoidosis [RETRACTED] | |
| Lee et al. | Ventricular ectopy in the context of left ventricular systolic dysfunction: risk factors and outcomes following catheter ablation | |
| Patel et al. | Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study | |
| Peretto et al. | Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease | |
| Zipse et al. | Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function | |
| Masuda et al. | An E/e′ ratio on echocardiography predicts the existence of left atrial low-voltage areas and poor outcomes after catheter ablation for atrial fibrillation | |
| Ghannam et al. | Risk stratification in patients with frequent premature ventricular complexes in the absence of known heart disease | |
| Ahn et al. | Prognostic implications of fragmented QRS and its relationship with delayed contrast-enhanced cardiovascular magnetic resonance imaging in patients with non-ischemic dilated cardiomyopathy | |
| Park et al. | Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy | |
| Shin et al. | Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy | |
| Rickard et al. | QRS fragmentation is not associated with poor response to cardiac resynchronization therapy | |
| Yu et al. | Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST‐segment elevation myocardial infarction | |
| Sohn et al. | Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: proposed modification of current guidelines | |
| Okutucu et al. | Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction | |
| Steffel et al. | Electrophysiological findings in patients with isolated left ventricular non-compaction | |
| Jiménez-Candil et al. | Prognostic significance of nonsustained ventricular tachycardia episodes occurring early after implantable cardioverter-defibrillator implantation among patients with left ventricular dysfunction | |
| Kataoka et al. | Prolonged T-peak to T-end interval predicts implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis | |
| Ghannam et al. | Clinical significance of myocardial scar in patients with frequent premature ventricular complexes undergoing catheter ablation | |
| Bakker et al. | Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis | |
| Shinohara et al. | Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease | |
| Honarbakhsh et al. | Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion | |
| Jalanko et al. | Fibrosis and wall thickness affect ventricular repolarization dynamics in hypertrophic cardiomyopathy | |
| Cekirdekci et al. | Can abnormal dispersion of ventricular repolarization be a predictor of mortality in arrhythmogenic right ventricular cardiomyopathy: The importance of Tp‐e interval | |
| Masuda et al. | Atrial functional substrates for the prediction of atrial fibrillation recurrence after pulmonary vein isolation | |
| Zhou et al. | Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy |